Floris H. Groenendijk

MED12 Controls the Response to Multiple Cancer Drugs through Regulation of TGF-β Receptor Signaling

Sidong Huang, Michael Hölzel, Theo Knijnenburg et al. · Cell · 2012 · 427 citations · Full text

ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy

Floris H. Groenendijk, Jeroen de Jong, Elisabeth E. Fransen van de Putte et al. · European Urology · 2015 · 214 citations

Urology, Surgical Oncology, Erbb2 Mutations Characterize +10

<i>IDH1</i> mutations in low-grade astrocytomas predict survival but not response to temozolomide

Hendrikus J. Dubbink, Walter Taal, Ronald van Marion et al. · Neurology · 2009 · 187 citations

Clinical Validation of Whole Genome Sequencing for Cancer Diagnostics

Paul Roepman, Ewart de Bruijn, Stef van Lieshout et al. · Journal of Molecular Diagnostics · 2021 · 76 citations · Full text

Sorafenib synergizes with metformin in NSCLC through AMPK pathway activation

Floris H. Groenendijk, Wouter W. Mellema, Eline van der Burg et al. · International Journal of Cancer · 2014 · 75 citations · Full text

Chemoprevention Strategy, Cancer Biology, Tumor Biology +22